Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)’s share price was up 1% on Wednesday . The company traded as high as $3.04 and last traded at $2.91, with a volume of 650,830 shares. The stock had previously closed at $2.88.

Separately, Maxim Group reaffirmed a “buy” rating and issued a $10.00 target price on shares of Adamis Pharmaceuticals Corp. in a research note on Monday.

The company has a 50-day moving average price of $2.85 and a 200-day moving average price of $5.23. The firm’s market capitalization is $61.61 million.

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.